Hanson Wade, the London-based life sciences knowledge services specialist, has launched IO Combination Trials Intelligence.
Highlands Oncology Group Recognized With Corporate Sponsorship Award
Dr. Hershey Garner, of Highlands Oncology Group, Voted Best Oncologist in Northwest Arkansas By Readers' Poll
Jacques Corriveau joining as General Manager North America
Predictive Multi-Biomarkers for accelerated immuno-oncological progress
Highlands Oncology Group Voted Best of Best By Readers' Poll
Arkansas Breast Cancer Specialists is a Collaborative Effort to Ensure the Most Effective Treatments are Executed
Highlands Oncology Group Participated in 3rd Annual Screening and Care Conference Hosted By the Lung Cancer Alliance
Incoming leader brings more than 15 years of leadership experience to the role
Company Names Dr. Nick Poulios CEO
Strand NGS now supports large scale RNA- and small-RNA-Seq and Unique Molecular Identifiers (UMIs) for DNA-, RNA-, and small-RNA-Seq.
Planet TV is making it real with the work of one doctor who is ending death sentences and crushing cancer.
Highlands Oncology Group Will Sponsor Bike Ride Benefiting The Cancer Challenge
Highlands Oncology Group to Participate in 3rd Annual Screening and Care Conference Hosted By the Lung Cancer Alliance
Highlands Oncology Group Will Offer Free Prostate Cancer Screenings in October
Highlands Oncology Group Commends Two APRNs On Completing Advanced Oncological Certifications
Company will launch an AI platform and applications focused on Oncology for pharmaceutical companies and other health care partners
Groups Advocate for Local Control Over Siting of Wireless Antennas
World experts in Portland share the latest Trials and Studies for Cancer at the LDN 2017 Conference.
Leading physician on female cancers and a uterine cancer patient turn a "whispered" conversation into steps toward intimacy.
Highlands Oncology Group Excited to Welcome Sarah W. Jewell, M.D., to Team
Through non-profit crowd funding, 2redWinery's winemaker rewards supporters with award-winning red wines to fund prostate cancer research.
Showing the ability of Alpha DaRT to effectively and safely destroy solid tumors, Alpha Tau Medical raises more capital than planned.
